www.hu-srb-ipa.com
www.recodac.pmf.uns.ac.rs
www.u-szeged.hu/fejlesztesiprojektek
Summary of RECODAC
project activities
PROJECT PARTNERS
Ez a dokumentum az Európai Unió pénzügyi támogatásával
valósult meg. A dokumentum tartalmáért teljes mértékben
az Újvidéki Egyetem Természettudományi és Matematikai
Kara válalja a felelőséget, és az semmilyen körülmények
között nem tekinthető az Európai Unió és/ vagy az Irányító
Hatóság állásfoglalást tükröző tartalomnak.
Ovaj document je odštampan uz finansijsku podršku
Evropske unije. Za sadržaj ovog dokumenta je odgovoran
isključivo Univerzitet u Novom Sadu, Prirodno-matematički
fakultet u Novom Sadu i sadržaj ovog dokumenta ne održava
zvanično mišljenje Evropske unije i/ili Direktorata.
This document has been produced with the financial
assistance of the European Union. The content of the
document is the sole responsibility of University of Novi
Sad Faculty of Sciences and can under no circumstances be
regarded as reflecting the position of the European Union
and/or the Managing Authority.
DR. MIHÁLY SZÉCSI, Lead Beneficary
TEL: +36 62 545 825
FAX: + 36 62 545 185
E-MAIL: [email protected]
WEB: www.u-szeged.hu
First Department of Medicine,
University of Szeged,
8-10 Korány fasor, 6725 Szeged, Hungary
DR. MARIJA SAKAČ, Project Manager
TEL: +381 21 485 2772
FAX: +381 21 455 662
E-MAIL: [email protected]
WEB: www.pmf.uns.ac.rs
University of Novi Sad Faculty of Sciences
Trg Dositeja Obradovića 3
21000 Novi Sad, Serbia
HUSRB/1002/214/133 • RECODAC
ORGANISED BY THE PROJECT:
PROJECT TITLE:
“Research Cooperation of the University of Szeged
and the University of Novi Sad in Development of
Anticancer Drug Compounds”
PROJECT ID: PROJECT ACRONYM:
HUSRB/1002/214/133
RECODAC
DATE:LOCATION:
November 27th, 2013
Meeting room 14/V
The project is co-financed by the
European Union
roject Closing Even
Project Closing Event
11:00 REGISTRATION
About the Project
RECODAC project aims at establishing new
cooperation between the University of Novi Sad
- prof. dr. Marija Sakač, project
11:30 Foreword
manager PP1
and the University of Szeged, covering the whole
research process of the synthesis and pre-clinical
studies of new antihormonal, potentially anticancer
11:40
Dr. Suzana Jovanović Šanta: Synthesis of
new antihormonal RECODAC compounds
- Overview of Project activities and
achievements at PP1-UNSPMF
12:00
Dr. Mihály Szécsi: Antihormonal effect
of RECODAC compounds - Overview of
Project activities and achievements at
LB-SZTE
on the steroid hormone metabolism and action, as
12:20
Round Table - The prosperity in the future
cooperation
objectives of this project. A very desirable goal -
13:00 REFRESHMENT
drug compounds. Modelling and preparation of new
compounds and screening of their effect exerted
well as development of drug candidates, possessing
antihormonal and anticancer effect, are specific
technologies development for the investigation of
the relations between the molecular structure and
antihormonal activity - may be applied for further
drug development studies. Special skills, competence
14:00 FAREWELL
FOR THE TEAM MEMBERS AND
15:00 LUNCH
ASSOCIATES
and joint expertise of the project research staff
gained by the knowledge transfer will provide another
durable output. Cooperation between Hungarian and
Serbian partners may offer research services in preclinical drug development, and it will continue even
after the project is finished.
Download

trifold letak.indd